MxA mRNA decrease preceding NAb detection in IFNβ‐treated MS patients

BACKGROUND: Multiple sclerosis (MS) patients treated with interferon beta (IFNβ) are at risk of a declining response to treatment because of the production of IFNβ‐neutralizing antibodies (NAbs). The expression of Myxovirus resistance protein A (MxA) mRNA is regarded as a marker of IFNβ bioactivity....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Brain Behav
Main Authors: Libertinova, Jana, Meluzinova, Eva, Matoska, Vaclav, Zajac, Miroslav, Kovarova, Ivana, Havrdova, Eva, Horakova, Dana, Tomek, Ales, Marusic, Petr, Bojar, Martin
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2017
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346526/
https://ncbi.nlm.nih.gov/pubmed/28293479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.644
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares